In vivo 31P-MRS assessment of muscle-pH, cytolsolic-[Mg 2+] and phosphorylation potential after supplementing hypokaliuric renal stone patients with potassium and magnesium salts

Renal stone patients in rural northeast Thailand have a low potassium and magnesium status and low urinary excretion of citrate. We measured the changes of urinary citrate excretion and assessed in vivo skeletal muscle metabolism for intracellular-pH, cytosolic-[Mg 2+] and phosphorylation potential...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Magnetic resonance imaging 2004-06, Vol.22 (5), p.715-719
Hauptverfasser: Mairiang, Eimorn, Hanpanich, Petcharakorn, Sriboonlue, Pote
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 719
container_issue 5
container_start_page 715
container_title Magnetic resonance imaging
container_volume 22
creator Mairiang, Eimorn
Hanpanich, Petcharakorn
Sriboonlue, Pote
description Renal stone patients in rural northeast Thailand have a low potassium and magnesium status and low urinary excretion of citrate. We measured the changes of urinary citrate excretion and assessed in vivo skeletal muscle metabolism for intracellular-pH, cytosolic-[Mg 2+] and phosphorylation potential (using the phosphorus magnetic resonance spectroscopy 31P-MRS) after oral supplementation to hypokaliuric renal stone patients with oral potassium and magnesium salts. The patients comprised four groups: Group 1 (n = 10) control, Group 2 (n = 3), Group 3 (n = 5) and Group 4 (n = 6) supplemented for a month with potassium citrate, potassium citrate plus amino acid chelated magnesium, and potassium-magnesium citrate, respectively. Though urinary citrate excretion was increased in all three supplemented groups, the increases in intracellular-pH, cytosolic-[Mg 2+] and phosphocreatine (PCr)/β-ATP were prominent only in Group 3. The increase in PCr/β-ATP was also observed in Group 4.
doi_str_mv 10.1016/j.mri.2004.01.038
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71978110</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0730725X04000566</els_id><sourcerecordid>71978110</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1966-99ca6dbe35aa86b953994c7527faeb873cdc044bbec8fe25a9a176bee267cc973</originalsourceid><addsrcrecordid>eNp9kcuKFDEUhoMoTs_oA7iRrNxolUndUsGVDDozMIPiBQSRkEqd6k6bqpQ5qZZ-LZ_Q9HSDOxchBL7_T3I-Qp5xlnPGm9fbfAw2LxircsZzVrYPyIq3oszqVlYPyYqJkmWiqL-dkXPELWOsLsr6MTnjNRcFa5oV-XMz0Z3deVryj9ndp89UIwLiCFOkfqDjgsZBNl-_omYfvUPvrMm-361p8fIH1VNP543HtMLe6Wj9RGcfU9ZqR_UQIVBc5tnBoc9Oa7rZz_6ndnYJ1tAAU8Iw-gnonNKJQfrbxs2hJL3DLuP9FaNeT3B_Qu0iPiGPBu0Qnp72C_L1_bsvl9fZ7Yerm8u3t5nhsmkyKY1u-g7KWuu26WRdSlkZURdi0NClKZnesKrqOjDtAEWtpeai6QCKRhgjRXlBXhx75-B_LYBRjRYNOKcn8AsqwaVoOWcJ5EfQBI8YYFBzsKMOe8WZOohSW5VEqYMoxbhKolLm-al86Ubo_yVOZhLw5ghA-uLOQlBo0oQM9DaAiar39j_1fwFgEajY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71978110</pqid></control><display><type>article</type><title>In vivo 31P-MRS assessment of muscle-pH, cytolsolic-[Mg 2+] and phosphorylation potential after supplementing hypokaliuric renal stone patients with potassium and magnesium salts</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Mairiang, Eimorn ; Hanpanich, Petcharakorn ; Sriboonlue, Pote</creator><creatorcontrib>Mairiang, Eimorn ; Hanpanich, Petcharakorn ; Sriboonlue, Pote</creatorcontrib><description>Renal stone patients in rural northeast Thailand have a low potassium and magnesium status and low urinary excretion of citrate. We measured the changes of urinary citrate excretion and assessed in vivo skeletal muscle metabolism for intracellular-pH, cytosolic-[Mg 2+] and phosphorylation potential (using the phosphorus magnetic resonance spectroscopy 31P-MRS) after oral supplementation to hypokaliuric renal stone patients with oral potassium and magnesium salts. The patients comprised four groups: Group 1 (n = 10) control, Group 2 (n = 3), Group 3 (n = 5) and Group 4 (n = 6) supplemented for a month with potassium citrate, potassium citrate plus amino acid chelated magnesium, and potassium-magnesium citrate, respectively. Though urinary citrate excretion was increased in all three supplemented groups, the increases in intracellular-pH, cytosolic-[Mg 2+] and phosphocreatine (PCr)/β-ATP were prominent only in Group 3. The increase in PCr/β-ATP was also observed in Group 4.</description><identifier>ISSN: 0730-725X</identifier><identifier>EISSN: 1873-5894</identifier><identifier>DOI: 10.1016/j.mri.2004.01.038</identifier><identifier>PMID: 15172066</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>31P-MRS ; Adult ; Citrates - analysis ; Citrates - metabolism ; Citrates - therapeutic use ; Citric Acid - urine ; Dietary Supplements ; Humans ; Hydrogen-Ion Concentration ; Intracellular-pH ; Kidney Calculi - drug therapy ; Kidney Calculi - metabolism ; Kidney Calculi - urine ; Magnesium ; Magnesium - administration &amp; dosage ; Magnesium - analysis ; Magnesium - metabolism ; Magnetic Resonance Spectroscopy ; Male ; Middle Aged ; Muscle, Skeletal - metabolism ; Phosphorus Isotopes ; Phosphorylation ; Potassium ; Potassium - administration &amp; dosage ; Potassium - metabolism ; Potassium - urine ; Potassium Deficiency - drug therapy ; Potassium Deficiency - urine ; Renal stone</subject><ispartof>Magnetic resonance imaging, 2004-06, Vol.22 (5), p.715-719</ispartof><rights>2004 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1966-99ca6dbe35aa86b953994c7527faeb873cdc044bbec8fe25a9a176bee267cc973</citedby><cites>FETCH-LOGICAL-c1966-99ca6dbe35aa86b953994c7527faeb873cdc044bbec8fe25a9a176bee267cc973</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.mri.2004.01.038$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15172066$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mairiang, Eimorn</creatorcontrib><creatorcontrib>Hanpanich, Petcharakorn</creatorcontrib><creatorcontrib>Sriboonlue, Pote</creatorcontrib><title>In vivo 31P-MRS assessment of muscle-pH, cytolsolic-[Mg 2+] and phosphorylation potential after supplementing hypokaliuric renal stone patients with potassium and magnesium salts</title><title>Magnetic resonance imaging</title><addtitle>Magn Reson Imaging</addtitle><description>Renal stone patients in rural northeast Thailand have a low potassium and magnesium status and low urinary excretion of citrate. We measured the changes of urinary citrate excretion and assessed in vivo skeletal muscle metabolism for intracellular-pH, cytosolic-[Mg 2+] and phosphorylation potential (using the phosphorus magnetic resonance spectroscopy 31P-MRS) after oral supplementation to hypokaliuric renal stone patients with oral potassium and magnesium salts. The patients comprised four groups: Group 1 (n = 10) control, Group 2 (n = 3), Group 3 (n = 5) and Group 4 (n = 6) supplemented for a month with potassium citrate, potassium citrate plus amino acid chelated magnesium, and potassium-magnesium citrate, respectively. Though urinary citrate excretion was increased in all three supplemented groups, the increases in intracellular-pH, cytosolic-[Mg 2+] and phosphocreatine (PCr)/β-ATP were prominent only in Group 3. The increase in PCr/β-ATP was also observed in Group 4.</description><subject>31P-MRS</subject><subject>Adult</subject><subject>Citrates - analysis</subject><subject>Citrates - metabolism</subject><subject>Citrates - therapeutic use</subject><subject>Citric Acid - urine</subject><subject>Dietary Supplements</subject><subject>Humans</subject><subject>Hydrogen-Ion Concentration</subject><subject>Intracellular-pH</subject><subject>Kidney Calculi - drug therapy</subject><subject>Kidney Calculi - metabolism</subject><subject>Kidney Calculi - urine</subject><subject>Magnesium</subject><subject>Magnesium - administration &amp; dosage</subject><subject>Magnesium - analysis</subject><subject>Magnesium - metabolism</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Muscle, Skeletal - metabolism</subject><subject>Phosphorus Isotopes</subject><subject>Phosphorylation</subject><subject>Potassium</subject><subject>Potassium - administration &amp; dosage</subject><subject>Potassium - metabolism</subject><subject>Potassium - urine</subject><subject>Potassium Deficiency - drug therapy</subject><subject>Potassium Deficiency - urine</subject><subject>Renal stone</subject><issn>0730-725X</issn><issn>1873-5894</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcuKFDEUhoMoTs_oA7iRrNxolUndUsGVDDozMIPiBQSRkEqd6k6bqpQ5qZZ-LZ_Q9HSDOxchBL7_T3I-Qp5xlnPGm9fbfAw2LxircsZzVrYPyIq3oszqVlYPyYqJkmWiqL-dkXPELWOsLsr6MTnjNRcFa5oV-XMz0Z3deVryj9ndp89UIwLiCFOkfqDjgsZBNl-_omYfvUPvrMm-361p8fIH1VNP543HtMLe6Wj9RGcfU9ZqR_UQIVBc5tnBoc9Oa7rZz_6ndnYJ1tAAU8Iw-gnonNKJQfrbxs2hJL3DLuP9FaNeT3B_Qu0iPiGPBu0Qnp72C_L1_bsvl9fZ7Yerm8u3t5nhsmkyKY1u-g7KWuu26WRdSlkZURdi0NClKZnesKrqOjDtAEWtpeai6QCKRhgjRXlBXhx75-B_LYBRjRYNOKcn8AsqwaVoOWcJ5EfQBI8YYFBzsKMOe8WZOohSW5VEqYMoxbhKolLm-al86Ubo_yVOZhLw5ghA-uLOQlBo0oQM9DaAiar39j_1fwFgEajY</recordid><startdate>200406</startdate><enddate>200406</enddate><creator>Mairiang, Eimorn</creator><creator>Hanpanich, Petcharakorn</creator><creator>Sriboonlue, Pote</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200406</creationdate><title>In vivo 31P-MRS assessment of muscle-pH, cytolsolic-[Mg 2+] and phosphorylation potential after supplementing hypokaliuric renal stone patients with potassium and magnesium salts</title><author>Mairiang, Eimorn ; Hanpanich, Petcharakorn ; Sriboonlue, Pote</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1966-99ca6dbe35aa86b953994c7527faeb873cdc044bbec8fe25a9a176bee267cc973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>31P-MRS</topic><topic>Adult</topic><topic>Citrates - analysis</topic><topic>Citrates - metabolism</topic><topic>Citrates - therapeutic use</topic><topic>Citric Acid - urine</topic><topic>Dietary Supplements</topic><topic>Humans</topic><topic>Hydrogen-Ion Concentration</topic><topic>Intracellular-pH</topic><topic>Kidney Calculi - drug therapy</topic><topic>Kidney Calculi - metabolism</topic><topic>Kidney Calculi - urine</topic><topic>Magnesium</topic><topic>Magnesium - administration &amp; dosage</topic><topic>Magnesium - analysis</topic><topic>Magnesium - metabolism</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Muscle, Skeletal - metabolism</topic><topic>Phosphorus Isotopes</topic><topic>Phosphorylation</topic><topic>Potassium</topic><topic>Potassium - administration &amp; dosage</topic><topic>Potassium - metabolism</topic><topic>Potassium - urine</topic><topic>Potassium Deficiency - drug therapy</topic><topic>Potassium Deficiency - urine</topic><topic>Renal stone</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mairiang, Eimorn</creatorcontrib><creatorcontrib>Hanpanich, Petcharakorn</creatorcontrib><creatorcontrib>Sriboonlue, Pote</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Magnetic resonance imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mairiang, Eimorn</au><au>Hanpanich, Petcharakorn</au><au>Sriboonlue, Pote</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vivo 31P-MRS assessment of muscle-pH, cytolsolic-[Mg 2+] and phosphorylation potential after supplementing hypokaliuric renal stone patients with potassium and magnesium salts</atitle><jtitle>Magnetic resonance imaging</jtitle><addtitle>Magn Reson Imaging</addtitle><date>2004-06</date><risdate>2004</risdate><volume>22</volume><issue>5</issue><spage>715</spage><epage>719</epage><pages>715-719</pages><issn>0730-725X</issn><eissn>1873-5894</eissn><abstract>Renal stone patients in rural northeast Thailand have a low potassium and magnesium status and low urinary excretion of citrate. We measured the changes of urinary citrate excretion and assessed in vivo skeletal muscle metabolism for intracellular-pH, cytosolic-[Mg 2+] and phosphorylation potential (using the phosphorus magnetic resonance spectroscopy 31P-MRS) after oral supplementation to hypokaliuric renal stone patients with oral potassium and magnesium salts. The patients comprised four groups: Group 1 (n = 10) control, Group 2 (n = 3), Group 3 (n = 5) and Group 4 (n = 6) supplemented for a month with potassium citrate, potassium citrate plus amino acid chelated magnesium, and potassium-magnesium citrate, respectively. Though urinary citrate excretion was increased in all three supplemented groups, the increases in intracellular-pH, cytosolic-[Mg 2+] and phosphocreatine (PCr)/β-ATP were prominent only in Group 3. The increase in PCr/β-ATP was also observed in Group 4.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>15172066</pmid><doi>10.1016/j.mri.2004.01.038</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0730-725X
ispartof Magnetic resonance imaging, 2004-06, Vol.22 (5), p.715-719
issn 0730-725X
1873-5894
language eng
recordid cdi_proquest_miscellaneous_71978110
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects 31P-MRS
Adult
Citrates - analysis
Citrates - metabolism
Citrates - therapeutic use
Citric Acid - urine
Dietary Supplements
Humans
Hydrogen-Ion Concentration
Intracellular-pH
Kidney Calculi - drug therapy
Kidney Calculi - metabolism
Kidney Calculi - urine
Magnesium
Magnesium - administration & dosage
Magnesium - analysis
Magnesium - metabolism
Magnetic Resonance Spectroscopy
Male
Middle Aged
Muscle, Skeletal - metabolism
Phosphorus Isotopes
Phosphorylation
Potassium
Potassium - administration & dosage
Potassium - metabolism
Potassium - urine
Potassium Deficiency - drug therapy
Potassium Deficiency - urine
Renal stone
title In vivo 31P-MRS assessment of muscle-pH, cytolsolic-[Mg 2+] and phosphorylation potential after supplementing hypokaliuric renal stone patients with potassium and magnesium salts
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T02%3A36%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vivo%2031P-MRS%20assessment%20of%20muscle-pH,%20cytolsolic-%5BMg%202+%5D%20and%20phosphorylation%20potential%20after%20supplementing%20hypokaliuric%20renal%20stone%20patients%20with%20potassium%20and%20magnesium%20salts&rft.jtitle=Magnetic%20resonance%20imaging&rft.au=Mairiang,%20Eimorn&rft.date=2004-06&rft.volume=22&rft.issue=5&rft.spage=715&rft.epage=719&rft.pages=715-719&rft.issn=0730-725X&rft.eissn=1873-5894&rft_id=info:doi/10.1016/j.mri.2004.01.038&rft_dat=%3Cproquest_cross%3E71978110%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71978110&rft_id=info:pmid/15172066&rft_els_id=S0730725X04000566&rfr_iscdi=true